Figure 1. Different Potential Sources of Trophic Signals That May Influence Motoneuron Survival
For references, see Oppenheim et al. (1993) . 
Is CT-1 the Long Sought after Target-Derived

Survival Factor for Motoneurons?
The latest addition to this list of putative motoneuron Brain-derived neurotrophic factor (BDNF) survival factors is CT-1 (Pennica et al., 1996) . CT-1, a recently discovered protein (Pennica et al., 1995a) , is a Choline acetyltransferase development factor (CDF) Ciliary neurotrophic factor (CNTF) member of the IL-6 family of cytokine growth factors Fibroblast growth factor-1 that also includes two previously identified members, Fibroblast growth factor-2 (FGF-2) CNTF and LIF, that promote motoneuron survival. CT-1 Fibroblast growth factor-5 induces hypertrophy and promotes survival of cultured Glial cell-line-derived neurotrophic factor (GDNF) cardiac myocytes, promotes the in vitro survival of rat Insulin dopaminergic neurons and chick ciliary neurons (PenInsulin-like growth factor-1 (IGF-1) Insulin-like growth factor-2 (IGF-2) nica et al., 1995b; Sheng et al., 1996) , and has now been shown in an elegant series of experiments to be present Leukemia inhibitor factor (LIF) in skeletal muscle and to promote the survival of culNeurite promoting factor (NPF) tured embryonic rat motoneurons (Pennica et al., 1996) . Initially, there was speculation that CT-1 might be a new ligand for the CNTF or LIF receptor based on reports Platelet-derived growth factor (PDGF) Protease nexin-1 (PN-1) that targeted deletion of either the ␣ subunit of the CNTF S-100 receptor or the LIF receptor ␤ subunit (which is common Transforming growth factor-␤ (TGF-␤) to both receptor complexes) results in a 40% loss of Vasoactive intestinal peptide (VIP) spinal and cranial motoneurons at birth (DiChiara et al., 1995; Li et al., 1995) , whereas null mutants for the ligands, CNTF or LIF, by contrast, fail to show this early (NGF; Purves and Sanes, 1987; Hamburger, 1993) . Almotoneuron loss (Masu et al., 1993; DiChiara et al., 1995 ; though NGF was shown to be important for the survival Escary et al., 1993) . The possibility that CT-1 might be of sensory and sympathetic neurons, motoneurons were a novel ligand for the CNTF and LIF receptors would found to be unresponsive. However, it was suspected explain these seemingly counterintuitive results. The that another factor (or factors) provided by skeletal musfacts, however, are a little more complicated than this cle plays a similar role for developing motoneurons as (Pennica et al., 1996) . Whereas CT-1 binds to the LIF-R␤ does target-derived NGF for sensory and sympathetic it does not bind to the CNTF-R␣, indicating the presence neurons.
of a novel cytokine receptor ␣ subunit that is necessary The Modern Search for Motoneuron to mediate the actions of CT-1.
Survival Factors
Because the recent history of this field provides sevAlthough several lines of evidence, including the limb eral examples of false hopes and unfulfilled promises, bud removal model, provided strong circumstantial eviit seems reasonable to ask what, if anything, about CT-1 dence for the existence of a muscle-derived motoneuron makes it a more plausible candidate target-derived mosurvival factor, the search for the specific molecule(s) toneuron trophic agent, compared with some of the involved was hindered by the lack of an appropriate in other previously highly acclaimed putative factors (e.g., vitro assay in which candidate molecules could be BDNF, NT-4, GDNF, and IGF). Before reviewing the evitested on purified populations of motoneurons (Varon et dence for CT-1, however, it is important to describe al., 1982). Beginning in the 1980s, however, increasingly some general criteria used to identify a molecule as a sophisticated techniques were established for culturing biologically relevant or necessary target-derived surenriched and completely purified populations of motovival factor for developing motoneurons. These include neurons (for references, see Dohrmann et al., 1986; Ara- the following. First, the factor should be present at the kawa et al ., 1990; Bloch-Gallego et al., 1991) . With these right time and place (i.e., in myotubes during motoneunew methods, it became possible to demonstrate unron PCD). Second, it should either be present in limiting equivocally that optimal motoneuron survival in vitro amounts or motoneurons should have limited access to depends on as yet unidentified proteins present in skeleit. Third, it should be secreted by target cells and interact tal muscle extracts. At about the same time, an in vivo with signal-transducing receptors at the nerve terminal. assay for testing the ability of muscle extracts and puriFourth, either the factor or the receptor-ligand complex fied proteins to prevent normal PCD of motoneurons in should be internalized and retrogradely transported and the chick embryo was developed (Oppenheim et al., should activate a signal transduction pathway that re-1988, 1993) . Because motoneurons continue to be desults in motoneuron survival. Fifth, the survival of homopendent on target-derived signals for a short time followgeneous cultures of motoneurons should be promoted ing the cessation of normal PCD, a third assay uses by physiological amounts of the factor. Sixth, in vivo trophic factors in an attempt to rescue motoneurons treatment should rescue motoneurons from normal from axotomy-induced cell death during this period (for PCD. Last, experimental reductions of endogenous levreferences, see Li et al., 1994) . Collectively, these assays els of the factor should result in the increased death of provided a powerful means for assessing the biological only those specific neurons thought to require the factor relevance of putative survival-promoting proteins for for their survival (e.g., motoneurons). For most of the motoneurons and their use has led to the identification factors listed in Table 1 , only one or two, or at best a of a relatively large number of candidate molecules, few, of these criteria have so far been satisfied, and CT-1 is no exception. In its favor, CT-1 is expressed at including several target-derived factors ( still be necessary to demonstrate that such a loss occurs Oppenheim, R.W. (1991) . Annu. Rev. Neurosci. 14, 453-501. by increased normal PCD rather than owing to effects on 
Why Are There So Many Factors That
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Promote Motoneuron Survival?
Armanini, M., Dudley, K., Phillips, H.S., Rosenthal, A., Kato, A.C., One obvious, albeit trivial, answer to this question is and Henderson, C.E. (1996) . Neuron 17, [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] that the action of many of the factors in Table 1 require different factors for survival; and motoneurons 453-472. require distinct factors at different stages of development. At present, the available evidence does not appear to strongly favor any one of these alternatives over the others, and it remains possible that they are all correct. (It is nonetheless intriguing that no single putative motoneuron survival factor [including CT-1] has been shown to maintain more than 40%-50% of motoneurons either in vitro or in vivo [for references, see Pennica et al., 1996; Oppenheim et al., 1993] .) Perhaps by this "embarrassment of riches," the embryo is trying to tell us something, but what? The hope, of course, is that future studies will reduce our ignorance on these matters and, in doing so, not only provide some final answers regarding the normal biology of motoneuron survival, but also suggest rational strategies as to how one might begin to use this information to treat human pathologies that involve the loss of motoneurons.
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